Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 39 - General protective or antinoxious agents
Patents for A61P 39 - General protective or antinoxious agents (19,019)
11/2000
11/02/2000EP1047769A1 Novel therapeutic uses of heterologous superoxide dismutase (hsd), and method for selecting said hsd
11/02/2000EP1047421A2 Inhibition of lipoprotein oxidation
11/02/2000CA2371242A1 Diagnosis of human kidney diseases
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2370600A1 Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
11/01/2000CN1272058A Perforated microparticles and methods of use
11/01/2000CN1271580A Medicine for treating and preventing saturnism and its preparing process
11/01/2000CN1057907C Anti-cadmium medicines and their synthesis and medical application
10/2000
10/31/2000US6140512 Process for the production of lipoic acid
10/31/2000US6140093 Nucleotide sequences coding an enzymatic protein for use as an antidote in organophorphous insecticide poisoning and to prevent neuronal cell
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063211A1 Haloalkoxy imidazonaphthyridines
10/26/2000WO2000062799A1 Hcv combination therapy, containing ribavirin in association with antioxidants
10/26/2000WO2000062789A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same
10/26/2000WO2000062740A2 Skin care compositions containing combination of skin care actives
10/26/2000CA2371399A1 Skin care compositions containing combination of skin care actives
10/26/2000CA2370231A1 Haloalkoxy imidazonaphthyridines
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/25/2000EP1046399A1 HCV combination therapy, containing ribavirin in association with antioxidants
10/25/2000EP1045936A1 Aqueous compositions comprising complexing agents and uses therof
10/25/2000EP1045851A1 Substituted porphyrins
10/25/2000CN1057695C Herbal medicine for giving up drug
10/24/2000US6136851 Skin disorders
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061549A2 Pharmaceutical compounds
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000WO2000061191A2 Heat stable coated colloidal iron oxides
10/19/2000WO2000061170A2 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000WO2000061130A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2370406A1 Pharmaceutical compounds
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369472A1 Novel medical use of alpha-1-acidic glycoprotein (aag or orosomucoid)
10/19/2000CA2369084A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood
10/19/2000CA2306039A1 Hcv combination therapy
10/18/2000EP1044975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid
10/18/2000EP1044217A2 Sag: sensitive to apoptosis gene
10/18/2000EP1043941A1 Revitalisation formulation
10/18/2000CN1270036A Chinese medicine for discharging garbage from body
10/18/2000CN1057462C Health-care drinking
10/17/2000US6132750 Particles of cross-linked proteins and polysaccharides with hydroxamic groups for chelating metals and their uses notably in cosmetics
10/12/2000WO2000059946A1 Hydroxymatairesinol in cancer prevention
10/12/2000WO2000059922A1 14,15-.alpha.-methylene equilenine derivatives, methods for producing the same and medicaments containing them
10/12/2000WO2000059899A1 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059493A2 Improved dialysis solutions and methods
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000DE19914101C1 Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik Perfluoralkylamide, their preparation and their use in the diagnosis
10/12/2000CA2369071A1 Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058281A1 Substrates for thioredoxin reductase
10/05/2000WO2000057727A1 Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and the use thereof for reducing transport through tight junctions
10/05/2000DE19915576A1 New equilenine derivatives, useful as antioxidative estrogenic hormonal steroids for e.g. prophylactic geriatrics in women and men
10/05/2000DE19915102A1 Treatment of cellular damage and disorders caused by reactive oxygen species e.g. atherosclerosis, ischemias or schizophrenia, by administration of limonene or oil containing it
10/05/2000CA2368484A1 Substrates for thioredoxin reductase
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/04/2000EP1041067A2 Use of 2-mercapto-imidazole derivatives substituted in position 4 ( or 5 ) as antioxidants
10/04/2000EP1039917A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039887A1 Methods for treatment of neuro- and nephro-disorders and therapeutic toxicities using aminothiol compounds
10/03/2000US6127348 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
09/2000
09/28/2000WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/28/2000WO2000056883A1 49 human secreted proteins
09/28/2000WO2000056881A1 48 human secreted proteins
09/28/2000WO2000056767A1 46 human secreted proteins
09/28/2000WO2000056755A1 49 human secreted proteins
09/28/2000WO2000056723A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/28/2000WO2000056341A1 Chemical compounds and their uses
09/28/2000WO2000056337A1 Agents for relieving side effects
09/28/2000CA2366877A1 Chemical compounds and their uses
09/28/2000CA2366267A1 49 human secreted proteins
09/28/2000CA2365247A1 49 human secreted proteins
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2362703A1 Perfluoroalkylamide, the production thereof and the use thereof in diagnostics
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038528A1 Pentosan polysulfate containing medicament and implant for treating fibrosis
09/27/2000EP1037911A1 Anti-pathogen system and methods of use thereof
09/27/2000EP1037629A2 Combination of a retinoic acid metabolism blocking agent and a tocophereol
09/27/2000EP1037621A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
09/27/2000EP1037596A1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners
09/27/2000EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
09/27/2000CN1268130A Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
09/27/2000CN1267529A Snake venom ointment and its preparation
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000054782A1 Treatment of accidental extravasation of anthracyclines
09/21/2000WO2000054756A2 Nitrate esters and their use for introducing neuroprotection and cognition enhancement
09/21/2000WO2000054754A2 Composition comprising isoquercetin and ascorbic acid in a sustained release form
09/21/2000WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock
09/21/2000WO2000018407A9 Methods for preventing/treating damage to sensory hair cells and cochlear neurons
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/14/2000WO2000053215A2 Deglycosylated ricin toxin a-chain vaccine
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 191